Global X Management Company’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Global X Management Company’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,171	Closed	-$123K	–	1197
2018 Q1	$123K	Buy	+7,171	New	+$140K	﹤0.01%	955
2017 Q3	–	Sell	-978	Closed	-$32K	–	1163
2017 Q2	$32K	Buy	978 +132	+16%	+$4.09K	﹤0.01%	1028
2017 Q1	$27K	Buy	846 +149	+21%	+$5.08K	﹤0.01%	1017
2016 Q4	$25K	Buy	697 +430	+161%	+$17.2K	﹤0.01%	965
2016 Q3	$12K	Sell	267 -214	-44%	-$11.2K	﹤0.01%	995
2016 Q2	$24K	Buy	481 +81	+20%	+$4.31K	﹤0.01%	865
2016 Q1	$21K	Sell	400 -25	-6%	-$1.47K	﹤0.01%	786
2015 Q4	$28K	Buy	425 +42	+11%	+$2.6K	﹤0.01%	446
2015 Q3	$22K	Sell	383 -117	-23%	-$7.59K	﹤0.01%	477
2015 Q2	$30K	Sell	500 -296	-37%	-$18.3K	﹤0.01%	450
2015 Q1	$50K	Hold	796	–	–	﹤0.01%	363
2014 Q4	$46K	Sell	796 -119	-13%	-$6.63K	﹤0.01%	376
2014 Q3	$49K	Buy	915 +309	+51%	+$16.4K	﹤0.01%	364
2014 Q2	$32K	Hold	606	–	–	﹤0.01%	383
2014 Q1	$32K	Buy	+606	New	+$28K	﹤0.01%	367

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Global X Management Company's TEVA Position: Q2 2018 in Review

Global X Management Company sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2018, closing a stake of 7,171 shares — an estimated $123K sold.

Global X Management Company first reported a position in TEVA in Q1 2014 and held it in 15 quarters. The position peaked at $123K in Q1 2018. 539 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

Global X Management Company reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2018 after selling out during the quarter.
Global X Management Company sold 7,171 Teva Pharmaceutical Industries Limited shares in Q2 2018, an estimated $123K.
Global X Management Company first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and held it in 15 quarters.
Global X Management Company's Teva Pharmaceutical Industries Limited position peaked at $123K in Q1 2018.
539 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.